Open original FDA record ↗Recall record
- FDA identifier
- Z-2144-2013
- Company in FDA record
- Genzyme Corporation, A Sanofi Company
- FDA classification date
- Sep 3, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Product contains particulates (fibers)
Source facts
- Action
- Genzyme sent a Medical Device Recall Notification letter dated June 21, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were avised to immediately discontinue use of all lots of LeGoo Endovascular Occlusion Gel and return all LeGoo and return product with the shipping label and packing slip enclosed. syringes.Complete the reply card via fax (414) 459-8791. Customer with questions were instructed to call GENCO at 877-674-2087. For questions regarding this recall call 508-270-2285.
- Initiated
- 2013-06-21
- Root cause
- Material/Component Contamination
- Terminated
- 2014-08-07
- Distribution
- Worldwide Distribution - USA (nationwide) and internationally to Austria, Belgium, Canada, Denmark, Egypt. Europe, Finland, France, Germany, Hong Kong, Ireland, Italy, Netherlands, Poland, Saudi Arabia, Slovena, Spain, Sweden, Switzerland, The Netherlands, Turkey, and UK.
- Recall number
- Z-2144-2013
- Recall status
- Terminated
- CDRH record ID
- 119113
- FDA classified
- 2013-09-03
- Recall event number
- 65485